Retention rates of adalimumab, etanercept and infliximab as...

  • Main
  • 2017 / 09
  • Retention rates of adalimumab, etanercept and infliximab as...

Retention rates of adalimumab, etanercept and infliximab as first-line biotherapy agent for rheumatoid arthritis patients in daily practice - Auvergne experience

Soubrier, Martin, Pereira, Bruno, Frayssac, Thomas, Fan, Angelique, Couderc, Marion, Malochet-Guinamand, Sandrine, Mathieu, Sylvain, Tatar, Zuzana, Tournadre, Anne, Dubost, Jean-Jacques
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Rheumatic Diseases
DOI:
10.1111/1756-185X.13156
Date:
September, 2017
File:
PDF, 197 KB
english, 2017
Conversion to is in progress
Conversion to is failed